Amylyx Pharmaceuticals (AMLX) Leases (2021 - 2025)
Historic Leases for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $5.5 million.
- Amylyx Pharmaceuticals' Leases rose 737.25% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 737.25%. This contributed to the annual value of $1.8 million for FY2024, which is 5245.64% down from last year.
- As of Q3 2025, Amylyx Pharmaceuticals' Leases stood at $5.5 million, which was up 737.25% from $5.8 million recorded in Q2 2025.
- Amylyx Pharmaceuticals' Leases' 5-year high stood at $6.8 million during Q1 2022, with a 5-year trough of $50000.0 in Q4 2021.
- Over the past 5 years, Amylyx Pharmaceuticals' median Leases value was $4.9 million (recorded in 2023), while the average stood at $4.2 million.
- Per our database at Business Quant, Amylyx Pharmaceuticals' Leases skyrocketed by 1094800.0% in 2022 and then plummeted by 6137.76% in 2025.
- Quarter analysis of 5 years shows Amylyx Pharmaceuticals' Leases stood at $50000.0 in 2021, then surged by 10948.0% to $5.5 million in 2022, then tumbled by 32.57% to $3.7 million in 2023, then tumbled by 52.46% to $1.8 million in 2024, then skyrocketed by 209.2% to $5.5 million in 2025.
- Its Leases was $5.5 million in Q3 2025, compared to $5.8 million in Q2 2025 and $1.3 million in Q1 2025.